4Limansky AS,Zamboni MI,Guardati MC. Evaluation of phenotypic and genotypic markers for clinical strains of A cinetobacter baumannii[J].Medicina(B Aires),2004,(04):306-312.
5Bou G,Cervem G,Dominguez MA. Characterization of nosocomialoutbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme:high—-level carbapenem resistance in A.baunumnii is not due solely to the presence of β-lactamase[J].Journal of Clinical Microbiology,2000.3299-3305.
6Isabelle Marchand,Laurence Damier-Piolle. Expression of the RND-Type Efiux Pump adeABC in Acinetobacter baumannii is Regulated by the AdeRS Two-Component System[J].Antimicrobial Agents and Chemotherapy,2004,(09):3298-3304.
8Jiménez-Mejías ME,Pach6n J,Becerril B. Treatment of multidrug-resistant Acinetobacter baumannii meningitis with ampicillin/sulbactam[J].Clinical Infectious Diseases,1997,(05):932-5.
9Michalopoulos A,Fotakis D,Virtzili S. Aerosolized colistin as adjunctive treatment of ventilator--associated pneumonia due to muhidrug--resistant Gram--negative bacteria:a prospective study[J].Respiratory Medicine,2008,(03):407-412.
5Naas T, Bogaerts P, Bauraing C, et al. Emergence of PER and VEB extended - spectrum betalactamases in Acinetobacter baumannii in Belgium[J]. JAntimicrob Chemother, 2006; 58:178 182.
6Poirel L, Cabanne L, Marque S,et al. Genetic environment and expression of the extended - spectrum beta - lactamase blaPER - 1 gene in gram - negative bacteria. Antimicrob [ J ]. Agents Chemother, 2005 ; 49:1708 -1713.
7Pasteran F, Rapoport M, Jones N, et al. Emergence of PER - 2 and VEB - 1 a in Acinetobacter baumannii strains in the Americas. Antimicrob[J]. Agents Chemother, 2006 ;50:3222 - 3224.
8Celenza G,Pellegrini C, Caccamo M, et al. Spread of bla(CTX- Mtype) and bla( PER -2 ) beta -lactamase genes in clinical isolates from Bolivian hospitals[ J]. J Antimicrob Chemother, 2006 ;57:975 - 978.
9Walsh TR. The emergence and implications of metallo - beta - lactamases in Gram - negative bacteria [J]. Clin Microbiol Infect, 2005 ; 11 (Suppl. 6) :S2 - S9.
10Walsh TR, Toleman MA, Poirel L, et al. Metallo - lactamases: the quiet before the storm [ J ] ? Clin Microbiol Rev,2005 ; 18:306 - 325.
6Rodríguez-Ba o J,Pascual A.Clinical significance of ex-tended-spectrum beta-lactemases[J].Expert Review of An-ti-infective Theray,2008,6(5):671.
7Johanson WG,Dever LL.Nosocomial pneumonia[J].In-tensive Care Med,2003,29(1):23.
8Corbella X,Montero A,Pujol M,et al.Emergence and rapid spread of earbapenem resistance during a large and sustained hospital outbreak of multiresistant Acineto-baeter baumannii[J].Clin Microbiol,2000,38(11):4086.
9Wilcox M, Nathwani D, Dryden M. Linezolid compared with teicoplanin for the treatment of suspected or proven Gram-positive infections [ J ]. J Antimicrob Chemother, 2004,53 : 335-344.
10Moise PA, Forrest A, Birmingham MC, et al. The efficacy and safety of linezolid as treatment for Staphylococcus aureus infectionsin compassionate use patients who are intolerant of, or who have failed to respond to, vancomycin [ J ]. J Antimicrob Chemother, 2002,50 : 1017-1026.
